Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Analysis and Forecast 2026-2032

Diamantane (CAS 2292-79-7) is a higher diamondoid, i.e., a saturated cage hydrocarbon whose carbon framework is an all-sp³, rigid three-dimensional network that mirrors local connectivity motifs found in the diamond lattice. With the molecular formula C₁₄H₂₀, diamantane can be viewed as an enlarged homolog of adamantane in which the cage is extended while preserving the low-strain, tetrahedral geometry and exceptional conformational rigidity characteristic of diamondoids; this structural logic underpins its high thermal robustness, chemical inertness under many conditions, and strongly hydrophobic surface character. In practice, diamantane is valued less as a bulk hydrocarbon than as a “hard” molecular scaffold that can be functionalized at defined positions to tune intermolecular packing, glass transition behavior, or surface interactions in specialty materials. Commercially, supply is typically positioned within the fluorine-free specialty hydrocarbon space: upstream feedstocks and separation logic often trace back to petroleum or C₅-stream–derived polycyclic intermediates; midstream producers focus on purification and controlled functionalization; downstream demand is driven by high-performance additives and molecular building blocks where rigidity, steric bulk, and thermal stability are monetized.

Adamantane (CAS 281-23-2) is the prototypical diamondoid (C₁₀H₁₆), defined by a highly symmetric, strain-minimized tricyclic cage of tetrahedral (sp³) carbon atoms that behaves as a rigid hydrocarbon “core” rather than a flexible ring system. This cage topology suppresses internal bond rotation relative to common cyclic hydrocarbons, which is why adamantane is widely used as a structure–property probe and as a robust scaffold for molecular design, including substituted derivatives where the cage imparts lipophilicity, steric definition, and thermal stability. Industrial manufacture is commonly based on acid-catalyzed skeletal rearrangement/isomerization of hydrogenated or partially hydrogenated dicyclopentadiene-derived polycyclic precursors, leveraging the C₅ petrochemical chain (DCPD from steam-cracker streams) as the practical upstream source; downstream, adamantane’s value chain is split between (i) pharmaceutical and fine-chemical derivatives built on the cage core and (ii) specialty materials uses where rigid, bulky, saturated frameworks improve thermal and mechanical performance.

According to APO Research, Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) should be treated as two separate markets with fundamentally different scale and operating logic: Diamantane is a catalog-grade, specification-led, kilogram-scale specialty chemical largely pulled by research and advanced materials programs, while Adamantane is a tonnage market shaped by multi-grade supply, downstream qualification requirements, and industrial cost structures. For Diamantane, global production value was about US$0.51 million in 2025 and is projected to reach US$0.70 million by 2030; output is expected to rise from roughly 7.05 kg in 2025 to 8.82 kg by 2030, with value growth driven more by purity, traceability, and documentation intensity than by volume expansion, and with North America, Japan, China, and Europe as the main value pools. For Adamantane, global production value was about US$209.28 million in 2025 and is projected to reach US$262.53 million by 2030; output is expected to increase from around 258.56 tons in 2025 to 332.45 tons by 2030, reflecting a more conventional industrial growth profile where the realized price level and margin structure are primarily governed by grade mix (industrial vs high-purity), quality-system capability, and supply reliability, with North America, China, Japan, and Europe remaining the core regional contributors by 2030.

This report presents an overview of global market for Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2), also provides the consumption of main regions and countries. Of the upcoming market potential for Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) sales, projected growth trends, production technology, application and end-user industry.

TCI America

City Chemical

Combi Blocks

Santa Cruz Biotechnology

abcr GmbH

BOC Sciences

Aceschem Inc

A2B Chem

Amadis Chemical

Chiralen Pharmaceutical

Starshine Chemical

Ambinter (Greenpharma)

AstaTech

Shanghai Maikelin Biochemical Technology

Aladdin

Chiron

Sigma-Aldrich

Thermo Scientific

Matrix Scientific

AbMole Bioscience

Smolecule

Biosynth

Alfa Chemistry

ChemScence

Fujifilm

Sichuan Zhongbang New Materials

Minxiang Pharmaceutical

Meryer (Shanghai) Chemical Technology

J&K Scientific

Purity: ≥98.0% (GC)

Purity: ＜98.0% (GC)

Chemical Reagent

Fine Chemicals

Pharmaceutical Intermediate

Material Intermediate

Medical

Scientific Research

Medical

Scientific Research

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.